• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Hexindai Inc.

    11/3/21 5:01:01 PM ET
    $HX
    Finance: Consumer Services
    Finance
    Get the next $HX alert in real time by email
    6-K 1 tm2131870d1_6k.htm FORM 6-K

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER
    PURSUANT TO RULE 13a-16 OR 15d-16
    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of November 2021

     

    Commission File Number: 001-38245

     

    Xiaobai Maimai Inc.

    (Exact name of registrant as specified in its charter)

     

    Room 515, Floor 5, Jia No. 92-4 to 24 Jianguo Road
    Chaoyang District, Beijing 100020
    People's Republic of China
    Tel: +86 10 5370 9902
     

    (Address of Principal Executive Offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

     

    Form 20-F x            Form 40-F ¨

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

     

     

     

     

     

    Exhibits.

     

    Exhibit No.   Description
    99.1   Notice of Annual General Meeting of Shareholders of Xiaobai Maimai Inc. to be held on December 3, 2021 (the “2021 AGM”)
    99.2   Form of Proxy Card for the 2021 AGM
    99.3   Depositary’s Notice of 2021 AGM
    99.4   Voting Instructions of American Depositary Shares for the 2021 AGM

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Xiaobai Maimai Inc.
       
      By: /s/ Zhang Rui (Kerrie)
    Date: November 3, 2021 Name: Zhang Rui (Kerrie)  
      Title: Chief Financial Officer

     

     

    Get the next $HX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Akso Health Group Announces Effective Date of Name Change and Ticker Symbol Change

    BEIJING, Dec. 16, 2021 /PRNewswire/ -- Akso Health Group ("Akso Health", the "Company" or "We") (NASDAQ:AHG), formerly known as Xiaobai Maimai Inc., today announced that the Company will update its name and ticker symbol on the Nasdaq Stock Market, effective at the start of trading on December 16, 2021 (the "Effective Date"). On the Effective Date, the Company's ADS and ordinary shares will be quoted under the new name "Akso Health Group" which was previously approved by the Company's shareholders (the "Name Change"), and the Company's ticker symbol will be updated to "AHG". Ms. Yilin Wang, Chairwoman and Chief Executive Officer of Akso Health, commented, "We are excited to align our Nasdaq

    12/16/21 6:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance

    Akso Health Group Reports Unaudited Financial Results for First Half of Fiscal Year 2022

    BEIJING, Dec. 15, 2021 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) ("Akso Health", the "Company" or "we"), formerly known as Xiaobai Maimai Inc., a social e-commerce platform in China, today announced its unaudited condensed consolidated financial results for the six months ended September 30, 2021. The Company amended the ratio of ADS and ordinary shares from one (1) ADS representing one (1) ordinary share to one (1) ADS representing three (3) ordinary shares, effective as of August 24, 2020. Fiscal year refers to the 12-month period ended March 31. First Half of Fiscal Year 2022 Highlights Number of Average Monthly Mobile Active Users[1] for the six months ended September 30, 2021 was 8

    12/15/21 6:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance

    Xiaobai Maimai Announces the Results of Annual General Meeting and Name Change

    BEIJING, Dec. 3, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai" or the "Company"), today announced that it held the 2021 annual general meeting of shareholders (the "AGM") at the Meeting Room, Futian Shangri-La, 4088 Yi Tian Road, Futian District, Shenzhen 518408, People's Republic of China, at 10:00 a.m. (Beijing Time) on December 3, 2021. At the AGM, holders of 71,057,650 ordinary shares (including ordinary shares represented by the Company's American Depositary Shares), out of the 71,478,550 ordinary shares issued and outstanding, were present in person or by proxy, and therefore constituted a quorum of more than one-third of the ordinary shares outstanding and ent

    12/3/21 4:10:00 PM ET
    $HX
    Finance: Consumer Services
    Finance

    $HX
    SEC Filings

    View All

    SEC Form 424B3 filed by Hexindai Inc.

    424B3 - Xiaobai Maimai Inc. (0001702318) (Filer)

    12/17/21 11:59:56 AM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form 6-K filed by Hexindai Inc.

    6-K - Xiaobai Maimai Inc. (0001702318) (Filer)

    12/15/21 8:30:19 AM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form 6-K filed by Hexindai Inc.

    6-K - Xiaobai Maimai Inc. (0001702318) (Filer)

    12/7/21 4:30:18 PM ET
    $HX
    Finance: Consumer Services
    Finance

    $HX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Hexindai Inc.

    SC 13D - Xiaobai Maimai Inc. (0001702318) (Subject)

    8/2/21 4:30:19 PM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form SC 13G/A filed by Hexindai Inc. (Amendment)

    SC 13G/A - Xiaobai Maimai Inc. (0001702318) (Subject)

    7/23/21 4:30:21 PM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form SC 13G/A filed

    SC 13G/A - Xiaobai Maimai Inc. (0001702318) (Subject)

    2/5/21 7:02:02 AM ET
    $HX
    Finance: Consumer Services
    Finance

    $HX
    Leadership Updates

    Live Leadership Updates

    View All

    Akso Health Group Reports Unaudited Financial Results for First Half of Fiscal Year 2022

    BEIJING, Dec. 15, 2021 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) ("Akso Health", the "Company" or "we"), formerly known as Xiaobai Maimai Inc., a social e-commerce platform in China, today announced its unaudited condensed consolidated financial results for the six months ended September 30, 2021. The Company amended the ratio of ADS and ordinary shares from one (1) ADS representing one (1) ordinary share to one (1) ADS representing three (3) ordinary shares, effective as of August 24, 2020. Fiscal year refers to the 12-month period ended March 31. First Half of Fiscal Year 2022 Highlights Number of Average Monthly Mobile Active Users[1] for the six months ended September 30, 2021 was 8

    12/15/21 6:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance

    Xiaobai Maimai Announces the Results of Annual General Meeting and Name Change

    BEIJING, Dec. 3, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai" or the "Company"), today announced that it held the 2021 annual general meeting of shareholders (the "AGM") at the Meeting Room, Futian Shangri-La, 4088 Yi Tian Road, Futian District, Shenzhen 518408, People's Republic of China, at 10:00 a.m. (Beijing Time) on December 3, 2021. At the AGM, holders of 71,057,650 ordinary shares (including ordinary shares represented by the Company's American Depositary Shares), out of the 71,478,550 ordinary shares issued and outstanding, were present in person or by proxy, and therefore constituted a quorum of more than one-third of the ordinary shares outstanding and ent

    12/3/21 4:10:00 PM ET
    $HX
    Finance: Consumer Services
    Finance

    Xiaobai Maimai Appoints Dr. Yingxian Liu as Medical Consultant for We Health Limited

    BEIJING, Oct. 22, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai," the "Company," or "we"), today announced the appointment of Dr. Yingxian Liu as the medical consultant to the Company. Dr. Liu will work closely with management to develop the Company's cancer therapy and radiation oncology business by the Company's wholly-owned subsidiary, We Health Limited. Dr. Liu received his medical degree from Sun Yat-sen University of Medical Sciences in Guangzhou, China. He completed his pathology residency at North Shore University Hospital in Manhasset, New York. Dr. Liu completed his hematopathology fellowship at Albert Einstein College of Medicine at Montefiore Medical Cente

    10/22/21 8:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance